BIOMAT Database Logo BIOMAT Database Logo

Cyclosporine-Induced Gingival Hypertrophy. 2019

Sheetanshu Kumar, and Ankur Guliani, and Keshavamurthy Vinay
Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005886 Gingival Hypertrophy Abnormal enlargement or overgrowth of the gingivae brought about by enlargement of existing cells. Gingival Hypertrophies,Hypertrophies, Gingival,Hypertrophy, Gingival
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000741 Anemia, Aplastic A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. Anemia, Hypoplastic,Aplastic Anaemia,Aplastic Anemia,Anaemia, Aplastic,Aplastic Anaemias,Aplastic Anemias,Hypoplastic Anemia,Hypoplastic Anemias
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

Sheetanshu Kumar, and Ankur Guliani, and Keshavamurthy Vinay
Treatment of cyclosporine-induced gingival hypertrophy.
March 1997, Annals of internal medicine,
Sheetanshu Kumar, and Ankur Guliani, and Keshavamurthy Vinay
Cyclosporine-induced gingival overgrowth.
August 1992, Transplantation proceedings,
Sheetanshu Kumar, and Ankur Guliani, and Keshavamurthy Vinay
Cyclosporine Induced Gingival Hyperplasia.
June 2021, The Journal of the Association of Physicians of India,
Sheetanshu Kumar, and Ankur Guliani, and Keshavamurthy Vinay
Nifedipine-induced gingival hypertrophy.
January 2012, Internal medicine (Tokyo, Japan),
Sheetanshu Kumar, and Ankur Guliani, and Keshavamurthy Vinay
Amlodipine-induced gingival hypertrophy.
August 2020, European journal of internal medicine,
Sheetanshu Kumar, and Ankur Guliani, and Keshavamurthy Vinay
Cyclosporine-induced gingival overgrowth-Review.
December 2022, Dermatologic therapy,
Sheetanshu Kumar, and Ankur Guliani, and Keshavamurthy Vinay
[Gingival hypertrophy due to cyclosporine. A review of the literature].
November 1996, Minerva stomatologica,
Sheetanshu Kumar, and Ankur Guliani, and Keshavamurthy Vinay
[Gingival hypertrophy induced by diphenylhydantoin].
March 1989, La Clinica terapeutica,
Sheetanshu Kumar, and Ankur Guliani, and Keshavamurthy Vinay
Amlodipine-induced massive gingival hypertrophy.
April 2011, Canadian family physician Medecin de famille canadien,
Sheetanshu Kumar, and Ankur Guliani, and Keshavamurthy Vinay
[Pathogenesis of cyclosporine induced gingival overgrowth].
May 2003, Minerva stomatologica,
Copied contents to your clipboard!